{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:50:10Z","timestamp":1785757810893,"version":"3.56.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tertiary lymphoid structures (TLS) are ectopic lymphoid aggregates that arise in non-lymphoid tissues under conditions of chronic inflammation, including cancer. Structurally and functionally resembling secondary lymphoid organs, TLS consist of organized T-cell zones, B-cell follicles, dendritic cells, high endothelial venules, and specialized stromal cells, enabling local antigen presentation and adaptive immune activation. In melanoma, the prototypical immunogenic tumor, the presence of TLS within the tumor microenvironment has been associated with enhanced immune surveillance and favorable clinical outcomes. However, emerging evidence indicates that TLS can also harbor immunosuppressive niches, potentially depending on their developmental stage and cellular composition. In this review, we summarize the molecular and cellular mechanisms underlying TLS biogenesis and outline the experimental methodologies currently used for their identification and characterization, with a focus on melanoma. We examine the clinical relevance of TLS in both primary and metastatic melanomas and discuss strategies aimed at inducing functional TLS within tumors. By promoting TLS formation to amplify intratumoral immune responses, these approaches hold promise for overcoming resistance to\u00a0immunotherapy and improving outcomes in advanced melanoma and other malignancies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1826453","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:33:33Z","timestamp":1785756813000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical impact and therapeutic potential of tertiary lymphoid structures in melanoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Daniele","family":"Carenza","sequence":"first","affiliation":[{"name":"Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bungaro","sequence":"additional","affiliation":[{"name":"Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Guida","sequence":"additional","affiliation":[{"name":"Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Apollonio","sequence":"additional","affiliation":[{"name":"Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.689270","article-title":"Tertiary lymphoid structures in cancer: The double-edged sword role in antitumor immunity and potential therapeutic induction strategies","volume":"12","author":"Kang","year":"2021","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70046","article-title":"The sunrise of tertiary lymphoid structures in cancer","volume":"332","author":"Rochefort","year":"2025","journal-title":"Immunol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1322035","article-title":"Tertiary lymphoid structures in autoimmune diseases","volume":"14","author":"Dong","year":"2023","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.medj.2024.10.023","article-title":"Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside","volume":"6","author":"Peyraud","year":"2025","journal-title":"Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.571545","article-title":"Integration of the tumor mutational burden and tumor heterogeneity identify an immunological subtype of melanoma with favorable survival","volume":"10","author":"Gao","year":"2020","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13046-026-03644-3","article-title":"Tertiary lymphoid structures in the era of cancer therapy","volume":"45","author":"Hern\u00e1ndez-Verdin","year":"2026","journal-title":"J Exp Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: Spatiotemporal heterogeneity, immune orchestration, and translational opportunities\u200b\u200b","volume":"18","author":"Deng","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.08.009","article-title":"Tertiary lymphoid structures and B cells: An intratumoral immunity cycle","volume":"56","author":"Fridman","year":"2023","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41467-022-35238-w","article-title":"A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer","volume":"14","author":"Tietscher","year":"2023","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120252","article-title":"Stromal cells in chronic inflammation and tertiary lymphoid organ formation","volume":"33","author":"Buckley","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8419104","article-title":"Lymphoid tissue mesenchymal stromal cells in development and tissue remodeling","volume":"2016","author":"Genovese","year":"2016","journal-title":"Stem Cells Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1905301116","article-title":"Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology","volume":"116","author":"Nayar","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: Immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1267654","article-title":"Mechanisms of tertiary lymphoid structure formation: Cooperation between inflammation and antigenicity","volume":"14","author":"Khanal","year":"2023","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189500","article-title":"Tumor-associated high endothelial venules as therapeutic modulation targets in cancer immunotherapy","volume":"1880","author":"Zhang","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-22-0110","article-title":"Sensory nerves impede the formation of tertiary lymphoid structures and development of protective antimelanoma immune responses","volume":"10","author":"Vats","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1186\/s12885-024-12587-x","article-title":"Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: A systematic review and meta-analysis","volume":"24","author":"Ma","year":"2024","journal-title":"BMC Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"16246","DOI":"10.1038\/s41598-024-64980-y","article-title":"The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer","volume":"14","author":"Weng","year":"2024","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-025-00346-2","article-title":"Impact of tertiary lymphoid structure scores and their stage of maturation on prognosis of colorectal cancer patients","volume":"26","author":"Shen","year":"2025","journal-title":"Genes Immun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001684","article-title":"Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: A multicenter retrospective cohort study","volume":"110","author":"Lei","year":"2024","journal-title":"Int J Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2929","article-title":"Early hepatic lesions display immature tertiary lymphoid structures and show elevated expression of immune inhibitory and immunosuppressive molecules","volume":"26","author":"Meylan","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15865","article-title":"Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures","volume":"44","author":"Ahn","year":"2024","journal-title":"Liver Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","article-title":"The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions","volume":"42","author":"MacFawn","year":"2024","journal-title":"Cancer Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.immuni.2025.09.018","article-title":"Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures","volume":"58","author":"Cakmak","year":"2025","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2023.100063","article-title":"Standardized pathology screening of mature tertiary lymphoid structures in cancers","volume":"103","author":"Vanhersecke","year":"2023","journal-title":"Lab Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00421-7","article-title":"Multi-resolution deep learning characterizes tertiary lymphoid structures and their prognostic relevance in solid tumors","volume":"4","author":"van Rijthoven","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41698-024-00579-w","article-title":"Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response","volume":"8","author":"Chen","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1205-7_40","article-title":"Multiplex immunofluorescence histology for immune cell infiltrates in melanoma-associated tertiary lymphoid structures","volume":"2265","author":"Mauldin","year":"2021","journal-title":"Methods Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.675146","article-title":"A standardized analysis of tertiary lymphoid structures in human melanoma: Disease progression- and tumor site-associated changes with germinal center alteration","volume":"12","author":"Werner","year":"2021","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1568456","article-title":"Spatial proteomics of the tumor microenvironment in melanoma: Current insights and future directions","volume":"16","author":"Bungaro","year":"2025","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.636057","article-title":"A multi-omics analysis of metastatic melanoma identifies a germinal center-like tumor microenvironment in HLA-DR-positive tumor areas","volume":"11","author":"Gadeyne","year":"2021","journal-title":"Front Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abk1692","article-title":"Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy","volume":"7","author":"Hoch","year":"2022","journal-title":"Sci Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-014-9784-8","article-title":"Ectopic lymphoid structures in primary cutaneous melanoma","volume":"20","author":"Lad\u00e1nyi","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"23097","DOI":"10.1038\/s41598-023-50327-6","article-title":"The molecular subtypes and clinical prognosis characteristic of tertiary lymphoid structures-related gene of cutaneous melanoma","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.immuni.2022.09.002","article-title":"Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response","volume":"55","author":"Liu","year":"2022","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.adz2742","article-title":"Pan-cancer spatial atlas of tertiary lymphoid structures","volume":"392","author":"Cho","year":"2026","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009231","article-title":"Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas","volume":"12","author":"Karapetyan","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000439","article-title":"Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures","volume":"28","author":"Stowman","year":"2018","journal-title":"Melanoma Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2164476","article-title":"Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas","volume":"12","author":"Edmonds","year":"2023","journal-title":"Oncoimmunology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008646","article-title":"Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma","volume":"12","author":"Su","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00891-z","article-title":"Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma","volume":"9","author":"Su","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nature25187","article-title":"High response rate to PD-1 blockade in desmoplastic melanomas","volume":"553","author":"Eroglu","year":"2018","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s40425-018-0479-7","article-title":"High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors","volume":"6","author":"Maleki Vareki","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004884","article-title":"Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites","volume":"10","author":"Conway","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002273","article-title":"Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma","volume":"9","author":"Lynch","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-014745","article-title":"Spatial and phenotypic plasticity of B cells in remodeling the tumor microenvironment","volume":"14","author":"Gao","year":"2026","journal-title":"J Immunother Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-12-1377","article-title":"Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases","volume":"72","author":"Cipponi","year":"2012","journal-title":"Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629519","article-title":"Cutaneous melanoma: Mutational status and potential links to tertiary lymphoid structure formation","volume":"12","author":"Salem","year":"2021","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004095","article-title":"Characterization of the treatment-naive immune microenvironment in melanoma with","volume":"10","author":"Wang","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3586","article-title":"Role of tumor-infiltrating B cells in clinical outcome of patients with melanoma treated with dabrafenib plus trametinib","volume":"27","author":"Brase","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111951","article-title":"BRAF and MEK inhibitors affect dendritic-cell maturation and T-cell stimulation","volume":"22","author":"Hoyer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1385802","article-title":"Association between tertiary lymphoid structures and clinical outcomes in cancer patients treated with immune checkpoint inhibitors: an updated meta-analysis","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/srep00765","article-title":"12-chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy","volume":"2","author":"Messina","year":"2012","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/his.12235","article-title":"The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma","volume":"63","author":"Avram","year":"2013","journal-title":"Histopathology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050908","article-title":"Tumoral C2 regulates the tumor microenvironment by increasing the ratio of M1\/M2 macrophages and tertiary lymphoid structures to improve prognosis in melanoma","volume":"16","author":"Zhang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s42003-022-04356-y","article-title":"Regulatory T cells infiltrate the tumor-induced tertiary lympho\u00efd structures and are associated with poor clinical outcome in NSCLC","volume":"5","author":"Devi-Marulkar","year":"2022","journal-title":"Commun Biol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1038\/s41467-024-46873-w","article-title":"Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer","volume":"15","author":"Kasikova","year":"2024","journal-title":"Nat Commun"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxac103","article-title":"A close-up on the expanding landscape of CD21-\/low B cells in humans","volume":"210","author":"Gjertsson","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2025.12.011","article-title":"B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity","volume":"44","author":"Chen","year":"2026","journal-title":"Cancer Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s44276-025-00146-1","article-title":"B cells and tertiary lymphoid structures in cancer therapy response","volume":"3","author":"Hegoburu","year":"2025","journal-title":"BJC Rep"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1130","article-title":"B cells and tertiary lymphoid structures: Friends or foes in cancer immunotherapy","volume":"28","author":"Lauss","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001906","article-title":"STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment","volume":"9","author":"Chelvanambi","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr1299","article-title":"Intratumoral antigen-presenting cell activation by a nanovesicle for the concurrent tertiary lymphoid structure de novo neogenesis","volume":"11","author":"Cheng","year":"2025","journal-title":"Sci Adv"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2093054","article-title":"Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation","volume":"11","author":"He","year":"2022","journal-title":"Oncoimmunology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12951-025-03301-5","article-title":"Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon","volume":"23","author":"Li","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado8395","article-title":"Synthetic biology-driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer","volume":"17","author":"Mi","year":"2025","journal-title":"Sci Transl Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00316","article-title":"Gel-trapped lymphorganogenic chemokines trigger artificial tertiary lymphoid organs and mount adaptive immune responses in vivo","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.31661","article-title":"Inverse opal hydrogel-collagen composite scaffolds as a supportive microenvironment for immune cell migration","volume":"85","author":"Stachowiak","year":"2008","journal-title":"J BioMed Mater Res A"},{"key":"B78","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41467-024-55430-4","article-title":"Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413286","article-title":"Artificial tertiary lymphoid structures: Exploring mesenchymal stromal cells as a platform for immune niche formation","volume":"25","author":"Zubkova","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-022-00856-8","article-title":"Orthogonally induced differentiation of stem cells for the programmatic patterning of vascularized organoids and bioprinted tissues","volume":"6","author":"Skylar-Scott","year":"2022","journal-title":"Nat BioMed Eng"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308760","article-title":"Rapid generation of hPSC-derived high endothelial venule organoids with in vivo ectopic lymphoid tissue capabilities","volume":"36","author":"Wang","year":"2024","journal-title":"Adv Mater"},{"key":"B82","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41392-024-02029-2","article-title":"Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13740","article-title":"Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10\/CXCR3 to boost antitumor immunity","volume":"58","author":"Zhang","year":"2025","journal-title":"Cell Prolif"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114120","article-title":"Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti-PD-1 therapy: MASTERKEY-115","volume":"207","author":"Robert","year":"2024","journal-title":"Eur J Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/CJI.0b013e31823731a4","article-title":"The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptides","volume":"35","author":"Harris","year":"2012","journal-title":"J Immunother"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000544","article-title":"Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment","volume":"8","author":"Pollack","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1334408","article-title":"Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2024.27","article-title":"Radiation drives tertiary lymphoid structures to reshape TME for synergized antitumour immunity","volume":"26","author":"Li","year":"2024","journal-title":"Expert Rev Mol Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00256","article-title":"Cellular composition and contribution of tertiary lymphoid structures to tumor immune infiltration and modulation by radiation therapy","volume":"8","author":"Boivin","year":"2018","journal-title":"Front Oncol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0196","article-title":"Stereotactic radiation therapy augments antigen-specific PD-1-mediated antitumor immune responses via cross-presentation of tumor antigen","volume":"3","author":"Sharabi","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s43018-026-01188-1","article-title":"The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets","volume":"7","author":"Kim","year":"2026","journal-title":"Nat Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.ccell.2025.07.013","article-title":"Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer","volume":"43","author":"Osorio","year":"2025","journal-title":"Cancer Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1826453\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:33:34Z","timestamp":1785756814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1826453\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":93,"alternative-id":["10.3389\/fimmu.2026.1826453"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1826453","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"article-number":"1826453"}}